Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.737
EU - Europa 4.080
AS - Asia 3.725
SA - Sud America 608
AF - Africa 91
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.258
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.597
SG - Singapore 1.323
RU - Federazione Russa 1.143
CN - Cina 865
IT - Italia 859
BR - Brasile 486
HK - Hong Kong 427
VN - Vietnam 362
DE - Germania 331
UA - Ucraina 320
FI - Finlandia 292
PL - Polonia 267
GB - Regno Unito 222
BD - Bangladesh 220
FR - Francia 189
IE - Irlanda 177
JP - Giappone 129
SE - Svezia 107
IN - India 86
CA - Canada 60
KR - Corea 60
AR - Argentina 45
MX - Messico 45
TR - Turchia 44
IQ - Iraq 38
NL - Olanda 36
AT - Austria 32
ZA - Sudafrica 23
RO - Romania 22
EC - Ecuador 18
UZ - Uzbekistan 18
BE - Belgio 17
CO - Colombia 16
PK - Pakistan 16
ES - Italia 15
ID - Indonesia 14
MY - Malesia 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
IR - Iran 11
PH - Filippine 11
VE - Venezuela 11
JO - Giordania 10
PY - Paraguay 10
AU - Australia 9
KE - Kenya 9
TN - Tunisia 9
CL - Cile 8
EG - Egitto 8
GE - Georgia 8
GR - Grecia 8
SA - Arabia Saudita 8
CH - Svizzera 7
CI - Costa d'Avorio 7
JM - Giamaica 7
DZ - Algeria 6
HN - Honduras 6
IL - Israele 6
LT - Lituania 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
ET - Etiopia 5
NP - Nepal 5
PS - Palestinian Territory 5
BF - Burkina Faso 4
BH - Bahrain 4
BO - Bolivia 4
KW - Kuwait 4
KZ - Kazakistan 4
OM - Oman 4
AO - Angola 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
RS - Serbia 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
DM - Dominica 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
BB - Barbados 1
CG - Congo 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
KH - Cambogia 1
Totale 17.241
Salva come PNG Salva come JPEG
Città #
Fairfield 1.081
Ashburn 976
Singapore 894
Woodbridge 564
Houston 501
Chandler 468
San Jose 439
Seattle 421
Wilmington 415
Hong Kong 411
Cambridge 354
Ann Arbor 282
Moscow 243
Zgierz 224
Dublin 178
Jacksonville 170
Palermo 169
Beijing 156
Medford 155
Santa Clara 142
Des Moines 126
Council Bluffs 125
Tokyo 121
Ho Chi Minh City 120
Altamura 117
Los Angeles 114
Frankfurt am Main 99
Lauterbourg 97
Princeton 97
Dallas 93
Lawrence 88
Nanjing 87
New York 83
Hefei 82
Hanoi 78
Helsinki 76
San Diego 69
Boardman 63
Buffalo 55
Chicago 52
São Paulo 52
Dearborn 49
The Dalles 49
Tulsa 47
London 46
Milan 43
Columbus 35
Shenyang 35
Rome 31
Hebei 29
Warsaw 27
Ludwigshafen am Rhein 25
Da Nang 24
Changsha 23
Nanchang 23
Orem 23
Phoenix 23
Nuremberg 22
Rio de Janeiro 22
Saint Petersburg 21
Atlanta 20
Tianjin 20
Denver 19
Guangzhou 18
Jinan 18
Brussels 17
Redwood City 17
Amsterdam 16
Baghdad 16
San Paolo di Civitate 16
Seongnam 16
Jiaxing 15
Johannesburg 15
Mumbai 15
San Francisco 15
San Mateo 15
Zhengzhou 15
Brasília 14
Izmir 14
Kumar 14
Seoul 14
Stockholm 14
Toronto 14
Brooklyn 13
Falls Church 13
Paris 13
Tashkent 13
Vienna 13
Berlin 12
City of London 12
Manchester 12
Montreal 12
Ningbo 12
Belo Horizonte 11
Boston 11
Chennai 11
Florence 11
Polska 11
Ankara 10
Haiphong 10
Totale 11.301
Salva come PNG Salva come JPEG
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 363
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 283
Does pain intensity predict a poor opioid response in cancer patients? 275
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 272
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. 265
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 261
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 257
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 255
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 242
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 235
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 222
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. 214
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 214
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 213
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 203
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 202
Breakthrough pain in oncology: a longitudinal study. 201
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). 198
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule 198
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 197
Anticancer oral therapy: Emerging related issues 195
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. 194
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 192
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 191
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 188
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 187
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 185
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 185
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 185
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. 184
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach. 184
Oral versus intravenous vinorelbine: clinical safety profile 183
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 181
Oral vinorelbine may not induce acute pain at the tumor site. 180
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 180
Gastric metastasis from breast cancer 175
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin? 174
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 174
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. 172
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 171
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer 170
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma 170
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 170
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 169
Treatment of metastatic breast cancer with vinorelbine and docetaxel 169
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 168
Cetuximab in squamous cell head and neck carcinomas. 167
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 166
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) 165
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials 164
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 163
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 161
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 159
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 158
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. 158
Italian clinical research in non-small-cell lung cancer 157
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma 152
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 149
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 147
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial 146
Cetuximab: clinical results in colorectal cancer. 145
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 145
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 144
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 144
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 142
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 142
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 142
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 142
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale 138
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 137
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 137
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 136
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 135
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 133
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 129
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 128
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 128
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 126
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 126
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 124
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 123
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 122
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer 120
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 119
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study 119
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 118
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. 117
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) 110
GEMCITABINE AND CISPLATIN FOR INOPERABLE AND/OR METASTATIC BILIARY TREE CARCINOMAS: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM) 110
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 110
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 109
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 105
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 104
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma. 102
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 102
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 101
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 101
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 99
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 99
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. 97
Totale 16.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 0 0 160
2021/20221.196 79 260 13 62 58 42 69 57 145 149 62 200
2022/20231.411 134 321 27 126 162 232 91 80 136 12 46 44
2023/2024602 29 97 67 48 37 92 46 27 12 15 40 92
2024/20251.874 50 166 183 144 96 60 130 109 124 194 202 416
2025/20266.662 428 231 401 445 687 931 882 686 545 778 344 304
Totale 17.794